KRAS and familial pancreatic carcinoma: In mice with oncogenic Kras, a heterogenic knockout of MYC reduces the development of pancreatic cancer, and physiological elevation of MYC, induced by the insertion of two copies of ROSA-driven MYC, significantly worsened the survival in a mouse model of pancreatic cancer [29, 30].